Search research articles
Contact Us
Filters
Showing results (21-30 of 115) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2014
Perils of comparing toxicities between stereotactic body radiation and intensity-modulated radiation therapy for prostate cancer on the basis of incomplete demographic registries
Christopher R King, Michael S Steinberg, Pat Kupelian
International Journal of Radiation Oncology, Biology, Physics
|
January 17, 2009
Testicular dose from prostate cyberknife: a cautionary note
Christopher R King, Anthony Lo, Daniel S Kapp
European Urology Oncology
|
April 25, 2019
Reply to Marieke J. Krimphove, Junaid Nabi, Alexander P. Cole, and Quoc-Dien Trinh's Letter to the Editor re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192-8: Setting the Standard: The Importance of Defining the Standard of Care for Comparative Effectiveness Analyses
Amar U Kishan, Ryan R Cook, Christopher R King
JAMA
|
July 26, 2018
Optimal Treatment for High-Risk Prostate Cancer-Reply
Amar U Kishan, Ryan R Cook, Christopher R King
American Journal of Clinical Oncology
|
April 2, 2005
Prostate biopsy volume indices do not predict for significant Gleason upgrading
Christopher R King, Deep A Patel, Martha K Terris
International Journal of Radiation Oncology, Biology, Physics
|
April 27, 2007
Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients
Michael T Spiotto, Steven L Hancock, Christopher R King
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2008
Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy
Christopher R King, Michael T Spiotto, Daniel S Kapp
Technology in Cancer Research & Treatment
|
March 11, 2003
CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility
Christopher R King, Joerg Lehmann, John R Adler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 27, 2007
A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes
Annie Hsu, Todd Pawlicki, Gary Luxton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
In Regard to Mariados et al
Christopher R King, Mitch Kamrava, Pin-Chieh Wang, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 115) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2014
Perils of comparing toxicities between stereotactic body radiation and intensity-modulated radiation therapy for prostate cancer on the basis of incomplete demographic registries
Christopher R King, Michael S Steinberg, Pat Kupelian
International Journal of Radiation Oncology, Biology, Physics
|
January 17, 2009
Testicular dose from prostate cyberknife: a cautionary note
Christopher R King, Anthony Lo, Daniel S Kapp
European Urology Oncology
|
April 25, 2019
Reply to Marieke J. Krimphove, Junaid Nabi, Alexander P. Cole, and Quoc-Dien Trinh's Letter to the Editor re: Ronald D. Ennis, Liangyuan Hu, Shannon N. Ryemon, Joyce Lin, Madhu Mazumdar. Brachytherapy-based Radiotherapy and Radical Prostatectomy Are Associated with Similar Survival in High-risk Localized Prostate Cancer. J Clin Oncol 2018;36:1192-8: Setting the Standard: The Importance of Defining the Standard of Care for Comparative Effectiveness Analyses
Amar U Kishan, Ryan R Cook, Christopher R King
JAMA
|
July 26, 2018
Optimal Treatment for High-Risk Prostate Cancer-Reply
Amar U Kishan, Ryan R Cook, Christopher R King
American Journal of Clinical Oncology
|
April 2, 2005
Prostate biopsy volume indices do not predict for significant Gleason upgrading
Christopher R King, Deep A Patel, Martha K Terris
International Journal of Radiation Oncology, Biology, Physics
|
April 27, 2007
Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients
Michael T Spiotto, Steven L Hancock, Christopher R King
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2008
Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomy
Christopher R King, Michael T Spiotto, Daniel S Kapp
Technology in Cancer Research & Treatment
|
March 11, 2003
CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility
Christopher R King, Joerg Lehmann, John R Adler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 27, 2007
A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes
Annie Hsu, Todd Pawlicki, Gary Luxton, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 5, 2015
In Regard to Mariados et al
Christopher R King, Mitch Kamrava, Pin-Chieh Wang, et al.
Page
of 12